Experiences with SCC antigen, a new tumor marker for cervical carcinoma
Authors:
- W. EiermannWEW. Eiermann
- P. StieberPSP. Stieber
- A. SchneiderASA. Schneider
- A. Fateh-MoghadamAFA. Fateh-Moghadam
- H. HeppHHH. Hepp
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (11) , 1555-1559
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Bestimmung des SCC-Antigens im Serum von Patientinnen mit ZervixkarzinomGeburtshilfe und Frauenheilkunde, 1987
- CA-125 in gynecological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1987
- Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial Determinations and Tissue LocalizationCancer, 1985
- Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren*Geburtshilfe und Frauenheilkunde, 1985
- Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinomaCancer, 1984
- Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervixAmerican Journal of Obstetrics and Gynecology, 1983
- Biochemical markers in the plasma and tumors of patients with gynecologic malignanciesCancer, 1981
- Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progressCancer, 1979
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinomaCancer, 1977
- Carcinoembryonic antigen in patients with gynecologic malignanciesAmerican Journal of Obstetrics and Gynecology, 1975